the in vitro activity of erythromycin and ru-28965 ( a novel macrolide antimicrobial with improved pharmacokinetics ) was determined against a variety of anaerobic bacteria in anaerobic atmospheres with and without added carbon dioxide .
C0014806
erythromycin
C1136254
antimicrobial